Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7724)
All Articles published online
|
Apr 21, 2010 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sang LX, Chang B, Zhang WL, Wu XM, Li XH, Jiang M. Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J Gastroenterol 2010; 16(15): 1908-1915 [PMID: 20397271 DOI: 10.3748/wjg.v16.i15.1908] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1908.htm |
| Number | Citing Articles |
| 1 |
Abhishek Deshpande, Vinay Pasupuleti, Sherif B. Mossad, Marie Budev, Steven K. Schmitt, Rebecca Corey, Bijan Eghtesad, Steven D. Mawhorter, Adrian V. Hernandez, Anil Jain, Robin K. Avery. Use of Lactobacillus in Prevention of Recurrences of Clostridium difficile Infection in Solid Organ Transplant Recipients. Infectious Diseases in Clinical Practice 2013; 21(5): 292 doi: 10.1097/IPC.0b013e31828d7231
|
| 2 |
Antonella Gallo, Giovanna Passaro, Antonio Gasbarrini, Raffaele Landolfi, Massimo Montalto. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World Journal of Gastroenterology 2016; 22(32): 7186-7202 doi: 10.3748/wjg.v22.i32.7186
|
| 3 |
Jennifer L. Barnes, Kelly A. Tappenden. Nutrition in the Prevention and Treatment of Disease. 2013; : 739 doi: 10.1016/B978-0-12-391884-0.00039-1
|
| 4 |
Grainne Holleran, Loris Lopetuso, Valentina Petito, Cristina Graziani, Gianluca Ianiro, Deirdre McNamara, Antonio Gasbarrini, Franco Scaldaferri. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2017; 18(10): 2020 doi: 10.3390/ijms18102020
|
| 5 |
Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini, Diego Currò. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacology & Therapeutics 2015; 149: 191 doi: 10.1016/j.pharmthera.2014.12.006
|
| 6 |
A. Sarkar, C.S. Pitchumoni. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 37 doi: 10.1016/B978-0-12-804024-9.00004-5
|
| 7 |
Kyung Hun Lee, Chang Hwan Choi. The Effect of Probiotics in Ulcerative Colitis. The Korean Journal of Gastroenterology 2012; 60(2): 67 doi: 10.4166/kjg.2012.60.2.67
|
| 8 |
Lijun Peng, Yan Zhong, Aiping Wang, Zhisheng Jiang. Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial. Bioscience Reports 2019; 39(1) doi: 10.1042/BSR20180943
|
| 9 |
Dong Yeon Jeong, Seung Kim, Min Ji Son, Chei Yun Son, Jong Yeob Kim, Andreas Kronbichler, Keum Hwa Lee, Jae Il Shin. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review. Autoimmunity Reviews 2019; 18(5): 439 doi: 10.1016/j.autrev.2019.03.002
|
| 10 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
|
| 11 |
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
|
| 12 |
L. Lavari, P. Burns, R. Páez, J. Reinheimer, G. Vinderola. Study of the effects of spray drying in whey-starch on the probiotic capacity of Lactobacillus rhamnosus
64 in the gut of mice. Journal of Applied Microbiology 2017; 123(4): 992 doi: 10.1111/jam.13567
|
| 13 |
Hao Cheng, Juan Liu, Dandan Zhang, Jing Wang, Yuzhu Tan, Wuwen Feng, Cheng Peng. Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.817600
|
| 14 |
Meng-Lin Li, Shao-Peng Sun, Ke Sun, Bin Lv, Yi-Hong Fan. Role of tryptophan metabolism in inflammatory bowel disease. World Chinese Journal of Digestology 2023; 31(21): 896 doi: 10.11569/wcjd.v31.i21.896
|
| 15 |
Nahid Akter, Roshada Hashim, Huy Quang Pham, Seung-Dae Choi, Dong-Woo Lee, Jae-Ho Shin, Kammara Rajagopal. Lactobacillus acidophilus Antimicrobial Peptide Is Antagonistic to Aeromonas hydrophila. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.570851
|
| 16 |
Lei Wang, Na Qin, Liuliu Shi, Rujuan Liu, Ting Zhu. Gut Microbiota and Tryptophan Metabolism in Pathogenesis of Ischemic Stroke: A Potential Role for Food Homologous Plants. Molecular Nutrition & Food Research 2024; doi: 10.1002/mnfr.202400639
|
| 17 |
Alyssa M. Parian, Berkeley N. Limketkai, Neha D. Shah, Gerard E. Mullin. Nutraceutical Supplements for Inflammatory Bowel Disease. Nutrition in Clinical Practice 2015; 30(4): 551 doi: 10.1177/0884533615586598
|
| 18 |
Jason A. Hawrelak. Textbook of Natural Medicine. 2020; : 809 doi: 10.1016/B978-0-323-43044-9.00105-9
|
| 19 |
Stefanie Joos. Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease. Chinese Journal of Integrative Medicine 2011; 17(6): 403 doi: 10.1007/s11655-011-0758-3
|
| 20 |
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference. 2011; : 21 doi: 10.1201/b11184-4
|
| 21 |
Mikihiro Fujiya, Nobuhiro Ueno, Yutaka Kohgo. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clinical Journal of Gastroenterology 2014; 7(1): 1 doi: 10.1007/s12328-013-0440-8
|
| 22 |
Maria O'Sullivan, Tara Raftery. Advanced Nutrition and Dietetics in Gastroenterology. 2014; : 191 doi: 10.1002/9781118872796.ch3.14
|
| 23 |
Thabata Koester Weber, Isabel Polanco. Gastrointestinal Microbiota and Some Children Diseases: A Review. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/676585
|
| 24 |
Simon Jäger, Eduard F. Stange, Jan Wehkamp. Antimicrobial Peptides in Gastrointestinal Inflammation. International Journal of Inflammation 2010; 2010: 1 doi: 10.4061/2010/910283
|
| 25 |
Giovanni Tomasello, Vito Rodolico, Monica Zerilli, Anna Martorana, Fabio Bucchieri, Alessandro Pitruzzella, Antonella Marino Gammazza, Sabrina David, Francesca Rappa, Giovanni Zummo, Provvidenza Damiani, Salvatore Accomando, Manfredi Rizzo, Everly Conway de Macario, Alberto J.L. Macario, Francesco Cappello. Changes in Immunohistochemical Levels and Subcellular Localization After Therapy and Correlation and Colocalization With CD68 Suggest a Pathogenetic Role of Hsp60 in Ulcerative Colitis. Applied Immunohistochemistry & Molecular Morphology 2011; 19(6): 552 doi: 10.1097/PAI.0b013e3182118e5f
|
| 26 |
Anoop Kumar, Pradhan Bhat, Alip Borthakur, Waddah A. Alrefai, Pradeep K. Dudeja. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases. 2018; : 89 doi: 10.1007/978-1-4939-7534-1_5
|
| 27 |
Laura E. Matarese, Hossam M. Kandil. Preventing Bacteria‐Induced Disease With Bacteria. Nutrition in Clinical Practice 2012; 27(2): 242 doi: 10.1177/0884533612440250
|
| 28 |
Mark B. van der Waal, Joost Flach, Pamela D. Browne, Isolde Besseling-van der Vaart, Eric Claassen, Linda H.M. van de Burgwal. Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective. PharmaNutrition 2019; 7: 100139 doi: 10.1016/j.phanu.2018.100139
|
| 29 |
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov, Vadim Samusenkov, Walid Kamal Abdelbasset, Ghulam Yasin, Hawraa Jabbar Mohammad, Mohammed Abed Jawad, Trias Mahmudiono, Seyed Reza Hosseini‐Fard, Rasoul Mirzaei, Sajad Karampoor. The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A. Journal of Digestive Diseases 2022; 23(8-9): 412 doi: 10.1111/1751-2980.13131
|
| 30 |
Richard Fedorak, Denny Demeria. Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2012; 41(4): 821 doi: 10.1016/j.gtc.2012.08.003
|
| 31 |
Fergus Shanahan, Eamonn M.M. Quigley. Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies. Gastroenterology 2014; 146(6): 1554 doi: 10.1053/j.gastro.2014.01.050
|
| 32 |
Yi-Xiang Zhang, Xiao-Qian Chi, Meng Li, Wei Zhang, Ying Guan, Lian-Qiu Wu. Nicotine improves DSS-induced colitis by inhibiting NLRP3 and altering gut microbiota. Journal of Asian Natural Products Research 2024; 26(5): 616 doi: 10.1080/10286020.2024.2331773
|
| 33 |
Diego Currò, Gianluca Ianiro, Silvia Pecere, Stefano Bibbò, Giovanni Cammarota. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. British Journal of Pharmacology 2017; 174(11): 1426 doi: 10.1111/bph.13632
|
| 34 |
F.C.P. Tiago, B.A.A. Porto, N.S. Ribeiro, L.M.C. Moreira, R.M.E. Arantes, A.T. Vieira, M.M. Teixeira, S.V. Generoso, V.N. Nascimento, F.S. Martins, J.R. Nicoli. Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease. Beneficial Microbes 2015; 6(6): 807 doi: 10.3920/BM2015.0018
|
| 35 |
Ingrid Ordás, Lars Eckmann, Mark Talamini, Daniel C Baumgart, William J Sandborn. Ulcerative colitis. The Lancet 2012; 380(9853): 1606 doi: 10.1016/S0140-6736(12)60150-0
|
| 36 |
Cristiano Pagnini, Gianfranco Delle Fave, Giorgos Bamias. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World Journal of Immunology 2013; 3(3): 31-43 doi: 10.5411/wji.v3.i3.31
|
| 37 |
S. C. Ng, F. K. L. Chan, J. J. Y. Sung. Review article: the role of non-biological drugs in refractory inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2011; 33(4): 417 doi: 10.1111/j.1365-2036.2010.04541.x
|
| 38 |
Frank I. Scott, Faten N. Aberra. Medical Therapy of Ulcerative Colitis. 2014; : 209 doi: 10.1007/978-1-4939-1677-1_18
|
| 39 |
Hu Zhao, Taohui Ding, Yanglin Chen, Wenbin Yang, Jun Rao, Dan Liu, Bo Yi. Arecoline aggravates acute ulcerative colitis in mice by affecting intestinal microbiota and serum metabolites. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1197922
|
| 40 |
|
| 41 |
Luis Fontana, Miriam Bermudez-Brito, Julio Plaza-Diaz, Sergio Muñoz-Quezada, Angel Gil. Sources, isolation, characterisation and evaluation of probiotics. British Journal of Nutrition 2013; 109(S2): S35 doi: 10.1017/S0007114512004011
|
| 42 |
Li-Wei Feng, Yue Zhao. Efficacy and safety of probiotics in adults with ulcerative colitis: A meta-analysis of placebo-controlled trials. World Chinese Journal of Digestology 2019; 27(6): 367 doi: 10.11569/wcjd.v27.i6.367
|
| 43 |
György Miklós Buzás. Probiotics in gastroenterology – from a different angle. Orvosi Hetilap 2013; 154(8): 294 doi: 10.1556/OH.2013.29547
|
| 44 |
Ingvar Bjarnason, Guy Sission, Bu’Hussaine Hayee. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. Inflammopharmacology 2019; 27(3): 465 doi: 10.1007/s10787-019-00595-4
|
| 45 |
Gabriela Świrkosz, Aleksandra Szczygieł, Katarzyna Logoń, Martyna Wrześniewska, Krzysztof Gomułka. The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis—A Literature Review. Biomedicines 2023; 11(12): 3144 doi: 10.3390/biomedicines11123144
|
| 46 |
Hyunho Yoon, Yeo-Sang Yoon, Min-Soo Kim, Myung-Jun Chung, Do-Young Yum. A Probiotic Preparation Duolac-Gold Ameliorates Dextran Sulphate Sodium-induced Mouse Colitis by Downregulating the Expression of IL-6. Toxicological Research 2014; 30(1): 27 doi: 10.5487/TR.2014.30.1.027
|
| 47 |
|
| 48 |
Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, Toshiyuki Matsui, Fumihito Hirai, Nagamu Inoue, Jun Kato, Kenji Kobayashi, Kiyonori Kobayashi, Kazutaka Koganei, Reiko Kunisaki, Satoshi Motoya, Masakazu Nagahori, Hiroshi Nakase, Fumio Omata, Masayuki Saruta, Toshiaki Watanabe, Toshiaki Tanaka, Takanori Kanai, Yoshinori Noguchi, Ken-ichi Takahashi, Kenji Watanabe, Toshifumi Hibi, Yasuo Suzuki, Mamoru Watanabe, Kentaro Sugano, Tooru Shimosegawa. Evidence-based clinical practice guidelines for inflammatory bowel disease. Journal of Gastroenterology 2018; 53(3): 305 doi: 10.1007/s00535-018-1439-1
|
| 49 |
|
| 50 |
K. Draper, C. Ley, J. Parsonnet. Probiotic guidelines and physician practice: a cross-sectional survey and overview of the literature. Beneficial Microbes 2017; 8(4): 507 doi: 10.3920/BM2016.0146
|
| 51 |
Kajal Farahmandi, Sadegh Sulaimany. Advances in Probiotics for Health and Nutrition. 2024; doi: 10.5772/intechopen.109717
|
| 52 |
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian, Helena Tavares de Sousa, Axel Dignass, Franck Carbonnel. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn's and Colitis 2017; 11(7): 769 doi: 10.1093/ecco-jcc/jjx009
|
| 53 |
Joseph D. Feuerstein, Alan C. Moss, Francis A. Farraye. Ulcerative Colitis. Mayo Clinic Proceedings 2019; 94(7): 1357 doi: 10.1016/j.mayocp.2019.01.018
|
| 54 |
Taghi Amiriani, Niloofar Rajabli, Maryam Faghani, Sima Besharat, Gholamreza Roshandel, Atefeh Akhavan Tabib, Hamidreza Joshaghani. Effect of Lactocare® Synbiotic on Disease Severity in Ulcerative Colitis: A Randomized Placebo-Controlled Double-Blind Clinical Trial. Middle East Journal of Digestive Diseases 2019; 12(1): 27 doi: 10.15171/mejdd.2020.160
|
| 55 |
Zhongzhen Li, Haleh Vaziri. Treatment of chronic diarrhoea. Best Practice & Research Clinical Gastroenterology 2012; 26(5): 677 doi: 10.1016/j.bpg.2012.11.005
|
| 56 |
Hui Yang, Yang Lin, Yuchan Ma, Jiaru Li, Junxiang Li, Zeqi Huo, Pingrong Yang, Chunjiang Zhang. Screening Probiotics for Anti-Helicobacter pylori and Investigating the Effect of Probiotics on Patients with Helicobacter pylori Infection. Foods 2024; 13(12): 1851 doi: 10.3390/foods13121851
|
| 57 |
Suresh Antony, Marlina Ponce de Leon. Probiotics - Current Knowledge and Future Prospects. 2018; doi: 10.5772/intechopen.75077
|
| 58 |
Matthijs Bekkers, Bojan Stojkovic, Gerard E. Kaiko. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2021; 22(20): 11243 doi: 10.3390/ijms222011243
|
| 59 |
Yao Mianzhi, Nagendra P. Shah. Contemporary nucleic acid-based molecular techniques for detection, identification, and characterization of Bifidobacterium. Critical Reviews in Food Science and Nutrition 2017; 57(5): 987 doi: 10.1080/10408398.2015.1023761
|
| 60 |
Jennifer L. Barnes, Kelly A. Tappenden. Nutrition in the Prevention and Treatment of Disease. 2017; : 857 doi: 10.1016/B978-0-12-802928-2.00039-4
|
| 61 |
Anna Lyra, Markku Saarinen, Heli Putaala, Kaisa Olli, Sampo J. Lahtinen, Arthur C. Ouwehand, Mari Madetoja, Kirsti Tiihonen. Bifidobacterium animalisssp.lactis420 Protects against Indomethacin-Induced Gastric Permeability in Rats. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/615051
|
| 62 |
Allison Agus, Sébastien Massier, Arlette Darfeuille-Michaud, Elisabeth Billard, Nicolas Barnich. Understanding Host-Adherent-InvasiveEscherichia coliInteraction in Crohn’s Disease: Opening Up New Therapeutic Strategies. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/567929
|
| 63 |
Gerard E. Mullin. Probiotics and Digestive Disease. Nutrition in Clinical Practice 2012; 27(2): 300 doi: 10.1177/0884533612439609
|
| 64 |
Asa Hakansson, Goran Molin. Gut Microbiota and Inflammation. Nutrients 2011; 3(6): 637 doi: 10.3390/nu3060637
|
| 65 |
Joseph D. Feuerstein, Adam S. Cheifetz. Ulcerative Colitis. Mayo Clinic Proceedings 2014; 89(11): 1553 doi: 10.1016/j.mayocp.2014.07.002
|
| 66 |
Jinpei Dong, Guigen Teng, Tiantong Wei, Wen Gao, Huahong Wang, John Green. Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis. PLOS ONE 2016; 11(12): e0168785 doi: 10.1371/journal.pone.0168785
|
| 67 |
Priyanka Jadhav, Yan Jiang, Karolin Jarr, Cosima Layton, Judith F. Ashouri, Sidhartha R. Sinha. Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases. Nutrients 2020; 12(7): 2156 doi: 10.3390/nu12072156
|
| 68 |
Qi Xu, Xiangfei Li, Eryin Wang, Yufeng He, Boxing Yin, Dongsheng Fang, Gang Wang, Jianxin Zhao, Hao Zhang, Wei Chen. A cellular model for screening of lactobacilli that can enhance tight junctions. RSC Advances 2016; 6(113): 111812 doi: 10.1039/C6RA24148D
|
| 69 |
Farzaneh Fakharian, Behnoush Asgari, Ali Nabavi-Rad, Amir Sadeghi, Neda Soleimani, Abbas Yadegar, Mohammad Reza Zali. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.953718
|
| 70 |
T. Pan, H.Y. Guo, H. Zhang, A.P. Liu, X.X. Wang, F.Z. Ren. Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB/c mice. Beneficial Microbes 2014; 5(3): 315 doi: 10.3920/BM2013.0041
|
| 71 |
Natasha Campbell-McBride, Sarah M. Rice, Tamzyn Murphy. Ketogenic. 2023; : 383 doi: 10.1016/B978-0-12-821617-0.00001-2
|
| 72 |
Dirk Haller, Gerald Rimbach, Tilman Grune. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013; : 281 doi: 10.1007/978-3-642-29374-0_21
|
| 73 |
V. A. Aksenov, E. L. Nikonov. The application of probiotics for the treatment of inflammatory bowel diseases, hepatopathy, and infectious diseases. Dokazatel'naya gastroenterologiya 2017; 6(2): 35 doi: 10.17116/dokgastro20176235-45
|
| 74 |
Paulina Mazur-Kurach, Barbara Frączek, Andrzej T. Klimek. Does Multi-Strain Probiotic Supplementation Impact the Effort Capacity of Competitive Road Cyclists?. International Journal of Environmental Research and Public Health 2022; 19(19): 12205 doi: 10.3390/ijerph191912205
|
| 75 |
Glenn R. Gibson, Robert J. Brummer, Erika Isolauri, Herbert Lochs, Lorenzo Morelli, Theo Ockhuizen, Ian R. Rowland, Jürgen Schrezenmeir, Catherine Stanton, Kristin Verbeke. The design of probiotic studies to substantiate health claims.. Gut Microbes 2011; 2(5): 299 doi: 10.4161/gmic.2.5.18002
|
| 76 |
K. Draper, C. Ley, J. Parsonnet. A survey of probiotic use practices among patients at a tertiary medical centre. Beneficial Microbes 2017; 8(3): 345 doi: 10.3920/BM2016.0148
|
| 77 |
Jie Meng, Anurag Agrawal, Peter J. Whorwell. Refractory inflammatory bowel disease—could it be an irritable bowel?. Nature Reviews Gastroenterology & Hepatology 2013; 10(1): 58 doi: 10.1038/nrgastro.2012.173
|
| 78 |
Yong Jiang, Zhi‐Guang Zhang, Feng‐Xiang Qi, Ying Zhang, Tao Han. Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta‐analysis of randomized controlled trials. Chronic Diseases and Translational Medicine 2016; 2(1): 34 doi: 10.1016/j.cdtm.2016.07.002
|
| 79 |
A.M. van der Geest, J.J. Feddema, L.H.M. van de Burgwal, O.F.A. Larsen. The advising behaviour of healthcare professionals; considerations of dieticians and general practitioners regarding dairy and probiotic interventions. Journal of Functional Foods 2023; 105: 105558 doi: 10.1016/j.jff.2023.105558
|
| 80 |
Girish Deshpande, Shripad Rao, Sanjay Patole. Progress in the field of probiotics: year 2011. Current Opinion in Gastroenterology 2011; 27(1): 13 doi: 10.1097/MOG.0b013e328341373e
|
| 81 |
Jamil Ahmed, Bala S. Reddy, Lars Mølbak, Thomas D. Leser, John MacFie. Impact of probiotics on colonic microflora in patients with colitis: A prospective double blind randomised crossover study. International Journal of Surgery 2013; 11(10): 1131 doi: 10.1016/j.ijsu.2013.08.019
|
| 82 |
Y. Derwa, D. J. Gracie, P. J. Hamlin, A. C. Ford. Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2017; 46(4): 389 doi: 10.1111/apt.14203
|
| 83 |
Desislava Dimitrova-Yurukova, Nikola Boyanov, Ventsislav Nakov, Radislav Nakov. Diagnosis and management of irritable bowel syndrome-like symptoms in ulcerative colitis. Folia Medica 2022; 64(5): 733 doi: 10.3897/folmed.64.e66075
|
| 84 |
Racha El Hage, Emma Hernandez-Sanabria, Tom Van de Wiele. Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01889
|
| 85 |
Lisa Gruber, Dirk Haller. Metabonomics and Gut Microbiota in Nutrition and Disease. Molecular and Integrative Toxicology 2015; : 261 doi: 10.1007/978-1-4471-6539-2_13
|
| 86 |
Verena Grimm, Christian U. Riedel. Microbiota of the Human Body. Advances in Experimental Medicine and Biology 2016; 902: 109 doi: 10.1007/978-3-319-31248-4_8
|
| 87 |
|
| 88 |
Yasushi Yoshimatsu, Akihiro Yamada, Ryuichi Furukawa, Koji Sono, Aisaku Osamura, Kentaro Nakamura, Hiroshi Aoki, Yukiko Tsuda, Nobuo Hosoe, Nobuo Takada, Yasuo Suzuki. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World Journal of Gastroenterology 2015; 21(19): 5985-5994 doi: 10.3748/wjg.v21.i19.5985
|
| 89 |
Luigi Santacroce, Skender Topi, Lucrezia Bottalico, Ioannis Alexandros Charitos, Emilio Jirillo. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Current Issues in Molecular Biology 2024; 46(5): 4991 doi: 10.3390/cimb46050299
|
| 90 |
Mao‐cheng Sun, Fu‐cheng Zhang, Xue Yin, Bi‐jun Cheng, Chang‐hui Zhao, Yan‐ling Wang, Zheng‐zhe Zhang, Hong‐wei Hao, Tie‐hua Zhang, Hai‐qing Ye. Lactobacillus reuteri F‐9‐35 Prevents DSS‐Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice. Journal of Food Science 2018; 83(10): 2645 doi: 10.1111/1750-3841.14326
|